Exploring Zero Gravity’s Impact on Heart Function in HFpEF Patients

What happens to the human heart when gravity fades away? A new study has ventured into uncharted territory, examining how weightlessness influences heart function in patients with heart failure with preserved ejection fraction (HFpEF). The findings, published in JAMA Cardiology, offer fascinating insights into the mechanics of the human heart in space.

Journal: JAMA Cardiology, November 16, 2024 | Reading time: 6 minutes

The Study: Heart Failure Meets Zero Gravity

Heart failure with preserved ejection fraction (HFpEF) is a complex condition where the heart struggles to fill properly, leading to increased pressure in the left ventricle (LV). This study, led by Dr. Benjamin D. Levine and colleagues at the Institute for Exercise and Environmental Medicine at Texas Health Presbyterian Dallas, investigated how zero gravity (0G) alters these pressures in HFpEF patients with obesity.

Two patients—both with previously implanted CardioMems sensors to monitor pulmonary artery pressures—participated in the research. During parabolic flight, researchers measured pulmonary artery systolic (PASP), diastolic (PADP), and mean pressures (PAMP) across different gravity levels: 1G (Earth gravity), 0G (weightlessness), and 1.8G (hypergravity).

The results revealed a surprising shift. In zero gravity, PADP dropped significantly for both patients—by 8 mm Hg and 9 mm Hg, respectively—compared to Earth gravity. These findings suggest that external constraints, like the weight of the lungs and chest wall, play a crucial role in heart function. The removal of these forces in 0G created measurable changes in cardiac chamber compliance.

Implications and Challenges

The study offers a compelling glimpse into how environmental changes impact the heart, particularly in conditions like HFpEF. The observed drop in pressure hints at new therapeutic strategies. For example, reducing external constraints through targeted weight loss could improve symptoms and functional capacity in patients with the obese phenotype of HFpEF—a hypothesis supported by prior research.

However, limitations must be acknowledged. With just two participants, the study’s findings are not generalizable. Additionally, the mechanisms behind the observed changes remain uncertain. Could other factors, like paracardial fat or pericardial effects, also influence these results? Future research is needed to untangle these variables and explore long-term implications.

Glossary

• HFpEF: Heart failure with preserved ejection fraction, a condition where the heart cannot fill properly, leading to increased pressure.
• PADP: Pulmonary artery diastolic pressure, an indicator of heart pressure during relaxation.
• CardioMems sensor: An implantable device used to monitor pulmonary artery pressures in heart failure patients.
• Parabolic flight: A flight pattern that creates brief periods of weightlessness by following a parabolic trajectory.
• EDPVR: End-diastolic pressure-volume relationship, describing the heart’s ability to fill with blood relative to pressure.

Interactive Quiz

Enjoy this story? Subscribe to our newsletter at scienceblog.substack.com

Related